Guardia GDA - Search Results

1

The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.

Kosti A, de Araujo PR, Li WQ, Guardia GDA, Chiou J, Yi C, Ray D, Meliso F, Li YM, Delambre T, Qiao M, Burns SS, Lorbeer FK, Georgi F, Flosbach M, Klinnert S, Jenseit A, Lei X, Sandoval CR, Ha K, Zheng H, Pandey R, Gruslova A, Gupta YK, Brenner A, Kokovay E, Hughes TR, Morris QD, Galante PAF, Tiziani S, Penalva LOF. Kosti A, et al. Among authors: guardia gda. Genome Biol. 2020 Aug 6;21(1):195. doi: 10.1186/s13059-020-02115-y. Genome Biol. 2020. PMID: 32762776 Free PMC article.

2

Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development.

Velasco MX, Kosti A, Guardia GDA, Santos MC, Tegge A, Qiao M, Correa BRS, Hernández G, Kokovay E, Galante PAF, Penalva LOF. Velasco MX, et al. Among authors: guardia gda. RNA. 2019 Jul;25(7):768-782. doi: 10.1261/rna.069211.118. Epub 2019 Apr 19. RNA. 2019. PMID: 31004009 Free PMC article.

3

Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles.

Guardia GDA, Correa BR, Araujo PR, Qiao M, Burns S, Penalva LOF, Galante PAF. Guardia GDA, et al. NPJ Genom Med. 2020 Jan 16;5:2. doi: 10.1038/s41525-019-0108-5. eCollection 2020. NPJ Genom Med. 2020. PMID: 31969990 Free PMC article.

4

Synergism of Proneurogenic miRNAs Provides a More Effective Strategy to Target Glioma Stem Cells.

Kosti A, Barreiro R, Guardia GDA, Ostadrahimi S, Kokovay E, Pertsemlidis A, Galante PAF, Penalva LOF. Kosti A, et al. Among authors: guardia gda. Cancers (Basel). 2021 Jan 14;13(2):289. doi: 10.3390/cancers13020289. Cancers (Basel). 2021. PMID: 33466745 Free PMC article.

5

Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy.

Frau C, Jamard C, Delpouve G, Guardia GDA, Machon C, Pilati C, Nevé CL, Laurent-Puig P, Guitton J, Galante PAF, Penalva LO, Freund JN, de la Fouchardiere C, Plateroti M. Frau C, et al. Among authors: guardia gda. Cancer Res. 2021 May 15;81(10):2730-2744. doi: 10.1158/0008-5472.CAN-20-2450. Epub 2021 Mar 19. Cancer Res. 2021. PMID: 33741693

6

Reboot: a straightforward approach to identify genes and splicing isoforms associated with cancer patient prognosis.

Dos Santos FRC, Guardia GDA, Dos Santos FF, Ohara DT, Galante PAF. Dos Santos FRC, et al. Among authors: guardia gda. NAR Cancer. 2021 Jun 15;3(2):zcab024. doi: 10.1093/narcan/zcab024. eCollection 2021 Jun. NAR Cancer. 2021. PMID: 34316711 Free PMC article.

7

The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma.

Baroni M, Guardia GDA, Lei X, Kosti A, Qiao M, Landry T, Mau K, Galante PAF, Penalva LOF. Baroni M, et al. Among authors: guardia gda. Cells. 2021 Dec 25;11(1):56. doi: 10.3390/cells11010056. Cells. 2021. PMID: 35011618 Free PMC article.

8

Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains.

de Souza AS, de Freitas Amorim VM, Guardia GDA, Dos Santos FF, Ulrich H, Galante PAF, de Souza RF, Guzzo CR. de Souza AS, et al. Among authors: guardia gda. Viruses. 2022 Apr 16;14(4):827. doi: 10.3390/v14040827. Viruses. 2022. PMID: 35458557 Free PMC article. Review.

9

ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics.

Kosti A, Chiou J, Guardia GDA, Lei X, Balinda H, Landry T, Lu X, Qiao M, Gilbert A, Brenner A, Galante PAF, Tiziani S, Penalva LOF. Kosti A, et al. Among authors: guardia gda. Neuro Oncol. 2023 Mar 14;25(3):459-470. doi: 10.1093/neuonc/noac179. Neuro Oncol. 2023. PMID: 35862252 Free PMC article.

10

Regulation of the THRA gene, encoding the thyroid hormone nuclear receptor TRα1, in intestinal lesions.

Giolito MV, La Rosa T, Farhat D, Bodoirat S, Guardia GDA, Domon-Dell C, Galante PAF, Freund JN, Plateroti M. Giolito MV, et al. Among authors: guardia gda. Mol Oncol. 2022 Dec;16(22):3975-3993. doi: 10.1002/1878-0261.13298. Epub 2022 Oct 10. Mol Oncol. 2022. PMID: 36217307 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters